Table of Contents

company-logo

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian and pancreatic cancer, and other mesothelin-expressing tumors. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Harpoon Therapeutics Dividend Announcement

• Harpoon Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Harpoon Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Harpoon Therapeutics Dividend History

Harpoon Therapeutics Dividend Yield

Harpoon Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Harpoon Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Harpoon Therapeutics Financial Ratios

P/E ratio-122.60
PEG ratio2.06
P/B ratio20.01
ROE-19.66%
Payout ratio0.00%
Current ratio1.89
Quick ratio1.89
Cash Ratio0.98

Harpoon Therapeutics Dividend FAQ

Does Harpoon Therapeutics stock pay dividends?
Harpoon Therapeutics does not currently pay dividends to its shareholders.
Has Harpoon Therapeutics ever paid a dividend?
No, Harpoon Therapeutics has no a history of paying dividends to its shareholders. Harpoon Therapeutics is not known for its dividend payments.
Why doesn't Harpoon Therapeutics pay dividends?
There are several potential reasons why Harpoon Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Harpoon Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Harpoon Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Harpoon Therapeutics a dividend aristocrat?
Harpoon Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Harpoon Therapeutics a dividend king?
Harpoon Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Harpoon Therapeutics a dividend stock?
No, Harpoon Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Harpoon Therapeutics stocks?
To buy Harpoon Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Harpoon Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.